Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells
作者： Yun Jeong Lim , Jong Chul Rhee , Young Mee Bae , Wan Joo Chun
关键词:
摘要: Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells
sci-hub.st 参考文章(19)
Xiu-Xu Chen, Mao-De Lai, Yong-Liang Zhang, Qiong Huang, Less cytotoxicity to combination therapy of 5-fluorouracil and cisplatin than 5-fluorouracil alone in human colon cancer cell lines World Journal of Gastroenterology. ,vol. 8, pp. 841- 846 ,(2002) , 10.3748/WJG.V8.I5.841
Tomoko Hashimoto-Tamaoki, Jun-ichi Furuyama, Takehira Yamamura, Masafumi Noda, Hidenori Yanagi, Reigetsu Yoshikawa, Masato Kusunoki, Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Cancer Research. ,vol. 61, pp. 1029- 1037 ,(2001)
Yeong-Min Yoo, Sung-Vin Yim, Sung-Soo Kim, Hyun Yong Jang, Ho Zoo Lea, Geun-Cheal Hwang, Jong-Woo Kim, Soon-Ae Kim, Hee Jae Lee, Chang-Ju Kim, Joo-Ho Chung, Kang-Hyun Leem, Melatonin suppresses NO-induced apoptosis via induction of Bcl-2 expression in PGT-β immortalized pineal cells Journal of Pineal Research. ,vol. 33, pp. 146- 150 ,(2002) , 10.1034/J.1600-079X.2002.02899.X
Elena N Pugacheva, Alexey V Ivanov, Julia E Kravchenko, Boris P Kopnin, Arnold J Levine, Peter M Chumakov, Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracil. Oncogene. ,vol. 21, pp. 4595- 4600 ,(2002) , 10.1038/SJ.ONC.1205704
A.K. Kubba, Non steroidal anti-inflammatory drugs and colorectal cancer: is there a way forward? European Journal of Cancer. ,vol. 35, pp. 892- 901 ,(1999) , 10.1016/S0959-8049(99)00054-4
Sebastien Arico, Sophie Pattingre, Chantal Bauvy, Pierre Gane, Alain Barbat, Patrice Codogno, Eric Ogier-Denis, Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line. Journal of Biological Chemistry. ,vol. 277, pp. 27613- 27621 ,(2002) , 10.1074/JBC.M201119200
Chinthalapally V. Rao, Malisetty V. Swamy, Christopher R. Herzog, Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53. Cancer Research. ,vol. 63, pp. 5239- 5242 ,(2003)
Sabine Grösch, Irmgard Tegeder, Ellen Niederberger, Lutz Bräutigam, Gerd Geisslinger, COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib The FASEB Journal. ,vol. 15, pp. 2742- 2744 ,(2001) , 10.1096/FJ.01-0299FJE
N.K. Altorki, R.S. Keresztes, J.L. Port, D.M. Libby, R.J. Korst, D.B. Flieder, C.A. Ferrara, D.F. Yankelevitz, K. Subbaramaiah, M.W. Pasmantier, A.J. Dannenberg, Celecoxib, a Selective Cyclo-Oxygenase-2 Inhibitor, Enhances the Response to Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 21, pp. 2645- 2650 ,(2003) , 10.1200/JCO.2003.07.127
Weimin Fan, Korey R. Johnson, Kristy K. Young, Antagonistic interplay between antimitotic and G1-S arresting agents observed in experimental combination therapy. Clinical Cancer Research. ,vol. 5, pp. 2559- 2565 ,(1999)